Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cell Medx Corp
(OP:
CMXC
)
0.0200
UNCHANGED
Streaming Delayed Price
Updated: 11:01 AM EDT, Aug 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
15,000
Open
0.0200
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.0200
Today's Range
0.0200 - 0.0200
52wk Range
0.0002 - 0.2280
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Over $6M Bet On This Tech Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
January 11, 2024
The Dow Jones index closed higher by over 150 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
FDA Submission and Corporate Update
September 20, 2022
Carson City, Nevada--(Newsfile Corp. - September 20, 2022) - Cell MedX Corp. (OTC PINK: CMXC) ("Cell MedX" or the "Company"),...
Via
Newsfile
Exposures
COVID-19
Product Safety
Performance
YTD
-11.11%
-11.11%
1 Month
-33.33%
-33.33%
3 Month
-55.56%
-55.56%
6 Month
-32.89%
-32.89%
1 Year
-59.18%
-59.18%
More News
Read More
Cell MedX Corp. Files Premarket Notification (510K) with the US Food and Drug Administration and Receives Canadian Trademark
September 17, 2021
Via
Newsfile
Topics
Intellectual Property
Regulatory Compliance
Exposures
Intellectual Property
Legal
Product Safety
Cell MedX Corp. Converts Debt to Shares, Closes Non-Brokered Private Placement Financing, and Engages Investor Relations Consultants
May 26, 2021
Via
Newsfile
Topics
Regulatory Compliance
Exposures
Legal
Product Safety
Regulatory
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.